Computational Repurposing and Phytochemical Screening of Inhibitors Against ClpK from Klebsiella pneumoniae

preprint OA: closed CC-BY-4.0
📄 Open PDF Full text JSON View at publisher

Abstract

Over the years, the increase in antibiotic resistant Klebsiella pneumoniae has highlighted the urgent need for the identification of novel therapeutic compounds and targets. ClpK is a caseinolytic ATPase that plays an important role in protein quality control and thermotolerance, making it a promising drug target. This study used in silico methods including ADMET screening, molecular docking and molecular dynamics simulations to evaluate binding efficiency and dynamic stability of selected natural and synthetic compounds with ClpK under varying ionic conditions. ADMET screening of synthetic and natural compounds excluded compounds violating Lipinski’s rule of 5 or showing predicted toxicity. Sclerotiamide P was identified as the top binder (-10.9 kcal/mol), while compound D3 had the weakest binding (-4.5 kcal/mol). The top ten compounds with the most favourable binding scores were then further investigated using molecular dynamics simulations in the presence of NaCl and MgCl 2 . Trajectory and MM-GBSA binding analyses confirmed that ClpK-ligand complexes remained stable in both ionic environments, with negative binding free energy values indicative of favourable interactions. Overall, the study highlighted ADEP3 and sclerotiamide derivatives as promising ClpK inhibitors and provides a foundation for further experimental validation.
Full text 66,726 characters · extracted from preprint-html · click to expand
Computational Repurposing and Phytochemical Screening of Inhibitors Against ClpK from Klebsiella pneumoniae | bioRxiv /* */ /* */ <!-- <!-- /*! * yepnope1.5.4 * (c) WTFPL, GPLv2 */ (function(a,b,c){function d(a){return"[object Function]"==o.call(a)}function e(a){return"string"==typeof a}function f(){}function g(a){return!a||"loaded"==a||"complete"==a||"uninitialized"==a}function h(){var a=p.shift();q=1,a?a.t?m(function(){("c"==a.t?B.injectCss:B.injectJs)(a.s,0,a.a,a.x,a.e,1)},0):(a(),h()):q=0}function i(a,c,d,e,f,i,j){function k(b){if(!o&&g(l.readyState)&&(u.r=o=1,!q&&h(),l.onload=l.onreadystatechange=null,b)){"img"!=a&&m(function(){t.removeChild(l)},50);for(var d in y[c])y[c].hasOwnProperty(d)&&y[c][d].onload()}}var j=j||B.errorTimeout,l=b.createElement(a),o=0,r=0,u={t:d,s:c,e:f,a:i,x:j};1===y[c]&&(r=1,y[c]=[]),"object"==a?l.data=c:(l.src=c,l.type=a),l.width=l.height="0",l.onerror=l.onload=l.onreadystatechange=function(){k.call(this,r)},p.splice(e,0,u),"img"!=a&&(r||2===y[c]?(t.insertBefore(l,s?null:n),m(k,j)):y[c].push(l))}function j(a,b,c,d,f){return q=0,b=b||"j",e(a)?i("c"==b?v:u,a,b,this.i++,c,d,f):(p.splice(this.i++,0,a),1==p.length&&h()),this}function k(){var a=B;return a.loader={load:j,i:0},a}var l=b.documentElement,m=a.setTimeout,n=b.getElementsByTagName("script")[0],o={}.toString,p=[],q=0,r="MozAppearance"in l.style,s=r&&!!b.createRange().compareNode,t=s?l:n.parentNode,l=a.opera&&"[object Opera]"==o.call(a.opera),l=!!b.attachEvent&&!l,u=r?"object":l?"script":"img",v=l?"script":u,w=Array.isArray||function(a){return"[object Array]"==o.call(a)},x=[],y={},z={timeout:function(a,b){return b.length&&(a.timeout=b[0]),a}},A,B;B=function(a){function b(a){var a=a.split("!"),b=x.length,c=a.pop(),d=a.length,c={url:c,origUrl:c,prefixes:a},e,f,g;for(f=0;f<d;f++)g=a[f].split("="),(e=z[g.shift()])&&(c=e(c,g));for(f=0;f<b;f++)c=x[f](c);return c}function g(a,e,f,g,h){var i=b(a),j=i.autoCallback;i.url.split(".").pop().split("?").shift(),i.bypass||(e&&(e=d(e)?e:e[a]||e[g]||e[a.split("/").pop().split("?")[0]]),i.instead?i.instead(a,e,f,g,h):(y[i.url]?i.noexec=!0:y[i.url]=1,f.load(i.url,i.forceCSS||!i.forceJS&&"css"==i.url.split(".").pop().split("?").shift()?"c":c,i.noexec,i.attrs,i.timeout),(d(e)||d(j))&&f.load(function(){k(),e&&e(i.origUrl,h,g),j&&j(i.origUrl,h,g),y[i.url]=2})))}function h(a,b){function c(a,c){if(a){if(e(a))c||(j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}),g(a,j,b,0,h);else if(Object(a)===a)for(n in m=function(){var b=0,c;for(c in a)a.hasOwnProperty(c)&&b++;return b}(),a)a.hasOwnProperty(n)&&(!c&&!--m&&(d(j)?j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}:j[n]=function(a){return function(){var b=[].slice.call(arguments);a&&a.apply(this,b),l()}}(k[n])),g(a[n],j,b,n,h))}else!c&&l()}var h=!!a.test,i=a.load||a.both,j=a.callback||f,k=j,l=a.complete||f,m,n;c(h?a.yep:a.nope,!!i),i&&c(i)}var i,j,l=this.yepnope.loader;if(e(a))g(a,0,l,0);else if(w(a))for(i=0;i (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0];var j=d.createElement(s);var dl=l!='dataLayer'?'&l='+l:'';j.src='//www.googletagmanager.com/gtm.js?id='+i+dl;j.type='text/javascript';j.async=true;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-M677548'); Skip to main content Home About Submit ALERTS / RSS Search for this keyword Advanced Search New Results Computational Repurposing and Phytochemical Screening of Inhibitors Against ClpK from Klebsiella pneumoniae View ORCID Profile Tehrim Ballim , View ORCID Profile Thandeka Khoza doi: https://doi.org/10.1101/2025.11.28.691150 Tehrim Ballim 1 Department of Biochemistry, School of Life Sciences , Pietermaritzburg Campus, University of Kwa-Zulu Natal , Pietermaritzburg, Scottsville 3209, South Africa Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Tehrim Ballim Thandeka Khoza 1 Department of Biochemistry, School of Life Sciences , Pietermaritzburg Campus, University of Kwa-Zulu Natal , Pietermaritzburg, Scottsville 3209, South Africa 2 Department of Biotechnology and Food Technology, Faculty of Science, University of Johannesburg , Doornfontein Campus, Johannesburg 2050, South Africa Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Thandeka Khoza For correspondence: thandekak{at}uj.ac.za Abstract Full Text Info/History Metrics Preview PDF Abstract Over the years, the increase in antibiotic resistant Klebsiella pneumoniae has highlighted the urgent need for the identification of novel therapeutic compounds and targets. ClpK is a caseinolytic ATPase that plays an important role in protein quality control and thermotolerance, making it a promising drug target. This study used in silico methods including ADMET screening, molecular docking and molecular dynamics simulations to evaluate binding efficiency and dynamic stability of selected natural and synthetic compounds with ClpK under varying ionic conditions. ADMET screening of synthetic and natural compounds excluded compounds violating Lipinski’s rule of 5 or showing predicted toxicity. Sclerotiamide P was identified as the top binder (-10.9 kcal/mol), while compound D3 had the weakest binding (-4.5 kcal/mol). The top ten compounds with the most favourable binding scores were then further investigated using molecular dynamics simulations in the presence of NaCl and MgCl 2 . Trajectory and MM-GBSA binding analyses confirmed that ClpK-ligand complexes remained stable in both ionic environments, with negative binding free energy values indicative of favourable interactions. Overall, the study highlighted ADEP3 and sclerotiamide derivatives as promising ClpK inhibitors and provides a foundation for further experimental validation. 1.1. Introduction The Gram-negative pathogen, Klebsiella pneumoniae has drawn the attention of many researchers following its classification as a critical priority by the World Health Organization (WHO) ( Prestinaci et al ., 2015 ). This opportunistic pathogen accounts for 30% of Gram-negative nosocomial infections with a mortality rate of more than 50% ( Podschun and Ullmann, 1998 ). It can infect wounds, soft tissues, the respiratory tract and urinary tract of newborns, elderly and immunocompromised patients ( Bagley, 1985 , Li et al ., 2023 ). K. pneumoniae has displayed resistance to major classes of antibiotics, including carbapenems, cephalosporins, aminoglycosides, and fosfomycin ( Li et al ., 2023 , Daya et al ., 2022 ). This increasing antibiotic resistance is attributed to various mechanisms including enzymatic antibiotic modification or inactivation, biofilm formation and expression of antibiotic specific efflux pumps ( Li et al ., 2023 , Mulani et al ., 2019 ). The growing threat of antibiotic resistance underscores the urgent need to develop alternative therapeutic strategies to combat K. pneumoniae ( Mulani et al ., 2019 ). One such approach involves the design of inhibitors that selectively target proteins essential for its survival. Among these key survival proteins, are Caseinolytic (Clp) ATPases, which use the energy from ATP hydrolysis to drive the refolding or degradation of misfolded and aggregated proteins, thus maintaining protein quality control ( Motiwala et al ., 2022 , Culp and Wright, 2017 , Carroni et al ., 2017 , Lairson et al ., 2008 ). Inhibiting Clp ATPases compromises protein homeostasis by increasing the level of misfolded or aggregated proteins, ultimately resulting in cell toxicity and death ( Gersch et al ., 2015 ). Targeting these proteins therefore offers an opportunity to disrupt critical pathways without affecting host systems. Clp ATPases share the canonical Walker A and B motifs, which are essential for ATP binding and hydrolysis. The Walker A motif contains the GXXXXGK[T/S] consensus sequence; mutations in this region prevent nucleotide binding and lead to protein inactivation ( Seraphim and Houry, 2020 , Bouchnak and Van Wijk, 2021 ). The Walker B motif includes a conserved hydrophobic hhhhDE sequence, and mutations to this motif result in substrate trapping, where proteins bind to the chaperone but cannot be released resulting in proteotoxicity and cell death ( Bouchnak and Van Wijk, 2021 , Rei Liao and Van Wijk, 2019 ). The strict conservation of these motifs across bacterial species highlights their important role in Clp ATPase function and is consequently attractive for rational inhibitor design. Small-molecule inhibitors that disrupt ATP binding or hydrolysis at these sites could selectively inactivate Clp ATPases and protein homeostasis, providing a promising therapeutic target ( Berg et al ., 2007 ). In silico protein-ligand docking is an effective and valuable technique to explore how candidate ligands might interact with proteins ( Mfeka et al ., 2025 ). By simulating binding events, docking allows for the evaluation of both the preferred orientation of ligands within the active or binding site and their relative binding affinities ( Afriza et al ., 2018 , Shamsara, 2018 ). This approach, compared to experimental methods, is cost-effective and time-efficient, allowing for high-throughput screening of multiple ligands against target proteins ( Afriza et al ., 2018 ). To date, several natural and synthetic compounds targeting essential proteins in clinically relevant pathogens have been developed or isolated ( Chaturvedi and Shrivastava, 2005 , Plotniece et al ., 2023 , Xuan et al ., 2023 ), including inhibitors of Clp ATPases (such as ClpC, and ClpX) and Clp proteases (ClpP) ( Table 1 ). View this table: View inline View popup Table 1: Mode of action of the compounds targeting Clp ATPases and ClpP. To this date, inhibitors specifically targeting ClpK remain largely unexplored. ClpK is a thermotolerant Clp ATPase, first identified in K. pneumoniae, with later studies confirming its presence across multiple Klebsiella species ( Bojer et al ., 2010 , Bojer et al ., 2012 , Motiwala et al ., 2021 ). To address this knowledge gap, previously identified compounds and plant derived flavonoids such as quercetin, (-)-Epigallocatechin-3-Gallate (EGCG), and kaempferol which have been identified to inhibit other Clp ATPases, heat shock proteins and mitochondrial ATPases ( Khan et al ., 2013 , Zininga et al ., 2017 , Zanini et al ., 2007 ) were investigated. Candidate compounds were subjected to ADMET (absorption, distribution, metabolism, excretion, and toxicity) analysis to assess pharmacokinetic and safety profiles. The filtered compounds were then docked to ClpK, and the resulting interactions were evaluated by free-binding energy calculations, molecular dynamics simulations and post-dynamic analyses. 1.2. Results 1.2.1. ClpK modelling and binding pocket identification A homology model of ClpK ( Figure 1A ) was generated using the AlphaFold server. The model was evaluated for structural quality using structural parameters ( Figure 1B ) and displayed favourable stereochemical properties with 98.53% of residues in the most favoured region of the Ramachandran plot. Remaining parametric scores confirmed that the predicted ClpK structure was structurally reliable and suitable for further in silico analysis. Download figure Open in new tab Figure 1: ClpK modelled using the AlphaFold server. The structure was visualised and coloured using PyMol ( Schrödinger, 2015 ). Five domains: N-terminal domain (residues 1–244; purple); Nucleotide Binding Domain (NBD) 1 (residues 245–445; olive); the D1-small domain (residues 446–590; maroon); NBD2 (residues 591–814; lime); and the D2-small domain/ C-terminal domain (residues 815–952; orange). The Walker A and Walker B motifs were coloured hot pink and cyan, respectively. To assess ClpK druggability prior to ligand screening, potential binding pockets were predicted using the DoGSiteScorer module on the ProteinPlus server, which identifies cavities based on a difference of Gaussian filter. A total of 29 potential binding sites were identified, of which 14 binding sites had a druggability score greater than 0.5. Among these 5 models exhibited a SimpleScore greater than 0.5, indicating favourable size, shape, and flexibility for ligand binding ( Figure 2A , 2B) ( Volkamer et al ., 2010 ). These pockets contained hydrophobic regions that facilitate protein-protein or protein-molecule interactions ( Jernigan et al ., 2022 ), as well as hydrogen acceptors and donors that further facilitate ligand binding ( Zhao and Huang, 2011 ) ( Figure 2A ). Collectively, these features confirmed ClpK as a druggable target suitable for subsequent docking analyses. Download figure Open in new tab Figure 2: Prediction of the potential binding pockets in ClpK. A) Quantitative properties of the predicted binding pockets. B) Visual representation of the top five predicted binding pockets on the ClpK. Each pocket is colour coded to correspond with the data in panel A: P_0 (yellow), P_1 (purple), P_2 (green), P_3 (red), and P_4 (blue). The ClpK backbone is shown in a cartoon representation as navy blue. 1.2.2. ADMET analysis To assess oral bioavailability and drug likeliness, the compounds were analysed according to Lipinski’s ‘rule of five,’ which outlines key physicochemical criteria for drug-like behaviour ( Varma et al ., 2006 ). According to these rules, a compound is considered drug-like if it meets at least two of the following four criteria; i) molecular weight less than 500, ii) calculated LogP (cLogP) value less than 5, iii) less than 10 H-bond acceptors and iv) less than 5 H-bond donors ( Ali et al ., 2023 ). The cLogP value indicates the hydrophilic (negative values) or lipophilic nature of a compound ( Silakari and Singh, 2021 ). All selected small ligands satisfied these criteria, indicating potentially suitability for oral administration ( Table 2 ). View this table: View inline View popup Download powerpoint Table 2: ADME properties of small ligands predicted using the SWISSADME server. The selected small ligands demonstrated distinct pharmacokinetic and toxicity profiles, as determined by SWISSADME and ProTox 3.0 analyses. Variations were observed in the predicted bioavailability, absorption, synthetic accessibility, BBB permeability, and toxicity indicating key differences in druggability and safety. The bio-availability score estimates how much of an orally administered compound reaches the blood; a value closer to 1 indicates better bioavailability ( Martin, 2005 ). Among the test ligands, acyldepsipeptide antibiotics (ADEPs) and epigallocatechin gallate (EGCG) had a bioavailability score of 0.17, indicating poor bioavailability, whereas the other ligands had scores >0.5, suggesting good bioavailability ( Daina et al ., 2017 ). Gastrointestinal (GI) absorption was high, except for ADEPs, EGCGs and (+)- hydantocidin. Synthetic accessibility scores were less than 5 for all except ADEPs, suggesting ease of synthesis. BBB permeability was observed for nine ligands, including G2 and D3. Toxicity classification ranged from Class 1 (most toxic, fatal if swallowed, ≤ 5 mg/kg) to Class 6 (non-toxic, > 5000 mg/kg); armeniaspirols A - C were predicted to be highly toxic and were excluded from further analysis ( Table 3 ) ( Ali et al ., 2023 , Alazmi and Motwalli, 2021 ). View this table: View inline View popup Download powerpoint Table 3: ADMET properties of small ligands predicted using the SWISSADME and ProTox 3.0 server. Among the large ligands, only Sclerotiamide derivatives fully complied with Lipinski’s rule of five, while other ligands violated one or more criteria. Maximum tolerated doses were less than 5 mg/kg/day, indicating high oral toxicity and suggesting the need for non-oral administration ( Ali et al ., 2023 ). Most ligands were lipophilic (logP > 0), supporting their formulation for non-oral routes, such as injections ( Han et al ., 2021 ). Sclerotiamides demonstrated logBB ≥ -1, while others showed poor penetration (logBB < -1). Sclerotiamide L was predicted to be toxic and excluded from subsequent analysis ( Table 4 ). View this table: View inline View popup Download powerpoint Table 4: ADMET analysis of the large ligands predicted using the pkCSM server. 1.2.3. Molecular Docking studies Molecular docking analysis revealed binding affinities ranging from -10.9 kcal/mol (Sclerotiamide P) to -4.5 kcal/mol (compound D3) indicating varying binding strengths ( Table 5 ). The top ten compounds with the most favourable (negative) binding affinities were selected for subsequent in silico analysis, including molecular dynamics simulation and binding free energy calculations. View this table: View inline View popup Download powerpoint Table 5: Molecular docking scores for ClpK-ligand complexes as obtained using AutoDock Vina on the PyRx software. The binding interactions of the top 10 ligands and ClpK were visualised in Figure 3 . All ligands formed multiple stabilising contacts with ClpK, including hydrogen bonds, π-π stacking, amide-π, and hydrophobic interactions, consistent with their docking affinities. Sclerotiamides and ADEP5 predominantly bind within Pocket 0 (N-terminal domain, NBD1, and D1-small domain), EGCG and ADEP1 bind within Pocket 3 (D1-small domain and NDB2 region), hydantoin and ADEP3 interacts in Pocket 1 (primarily engaging NBD1), and ADEP2 in Pocket 4 (making contacts within the N-terminal domain) ( Figure 2 , Figure 3 ). The following residues participated in multiple ligand interactions: PRO283, THR462, ASP282, LEU108, PHE197, VAL198, and GLY279, each involved in five or more ligands, suggesting their role as core binding sites thus suggesting their potential role in ligand recognition and stabilisation. Download figure Open in new tab Figure 3: Molecular interaction of ClpK with the top 10 ligands exhibiting the strongest binding affinities. Hydrogen bonds are represented by green balls and sticks, π-π/π-sigma/amide-π interactions are represented by violet balls and sticks, π-alkyl/alkyl interactions are presented by pink balls and sticks, π-sulphur bonds are represented by gold balls and sticks, and carbon-hydrogen bonds are represented as light green balls and sticks. 1.2.4. Molecular dynamics simulations MD simulations of 100 ns were performed to investigate ClpK-ligand interactions, stability, and conformational changes. The potential energy of a system indicates the energetic stability of the apo - and complexed ClpK structures ( Ajao et al ., 2012 ). The average potential energy of apo-ClpK was observed to be -2813010.92 kJ/mol in the presence of NaCl, and this increased slightly to -2859433.80 kJ/mol in the presence of MgCl 2, indicating a stable and well-equilibrated system under both ionic conditions. The increase in potential energy observed in the presence of compounds is expected as ligand binding would result in an increase in the systems total energy ( Figure 4 ). Despite these differences, the potential energy remains stable over the 100 ns simulation period suggesting that the systems reached equilibration and maintained energetic stability. Download figure Open in new tab Figure 4: Potential energy (kJ/mol) profiles of apo -ClpK and ClpK-compound complexes analysed over 100 ns. In the presence of A) NaCl and B) MgCl 2 . RMSD analysis showed an average of 0.941 nm for apo -ClpK in NaCl, increasing to 1.21 nm in MgCl 2 , indicating greater structural deviations and enhanced flexibility in the presence MgCl 2 ( Figure 5 ). Ligand binding increased RMSD in NaCl (1.01 nm to 1.62 nm), with ClpK-Sclerotiamide N showing the highest deviation (1.62 nm). In MgCl 2 , some complexes, notably ClpK-Sclerotiamide-B (1.14 nm) and ClpK-ADEP3 (1.06 nm), exhibited decreased RMSD, indicating stable ligand binding, while others, such as ClpK-ADEP2, displayed increased RMSD up to 1.76 nm, suggesting destabilisation ( Figure 5 ). Download figure Open in new tab Figure 5: RMSD profiles of apo -ClpK and ClpK-compound complexes over 100 ns molecular dynamics simulations. Simulations were run in the presence of A) NaCl and B) MgCl 2 . Residue flexibility over the 100 ns simulation was assessed using RMSF ( Figure 6 ). For apo-ClpK, average RMSF increased slightly from 0.37 nm in NaCl to 0.38 nm in MgCl 2 , consistent with the RMSD results, indicating that MgCl 2 affects structural stability. Ligand binding increased RMSF, ranging from 0.42 nm to 0.64 nm in NaCl and 0.41 nm to 0.62 nm in MgCl 2 . In NaCl, fluctuations were distributed across N-terminal, middle, and C-terminal domains, with Sclerotiamide N exhibiting the highest RMSF (0.64 nm), reflecting destabilisation. In MgCl 2, fluctuations were primarily at the C-terminal, with ADEP5 (0.62 nm) and ADEP2 (0.61 nm) complexes showing higher RMSF, corresponding to the destabilising effect observed in RMSD analysis. Download figure Open in new tab Figure 6: RMSF profiles of apo -ClpK and ClpK-compound complexes analysed over 100 ns. In the presence of A) NaCl and B) MgCl 2 . The Rg was used to assess the structural compactness of ClpK ( Figure 7 ). A po -ClpK maintained stable Rg values of 3.83 nm in NaCl and 3.85 nm in MgCl 2 . In NaCl, ligands such as Sclerotiamide B, ADEP1, ADEP5, and Hydantoin reduced Rg, indicating tighter conformations. In contrast, Sclerotiamide, Sclerotiamide N, Sclerotiamide P, EGCG, ADEP3 and ADEP2 showed increased Rg, suggesting loosening or partial unfolding. In MgCl 2 , most ligands maintained Rg values comparable to apo. However, Sclerotiamide B, ADEP1 and ADEP3 showed decreased Rg, while Sclerotiamide P, Hydantoin and ADEP2, suggesting Mg 2+ -dependent differences in ligand-induced relaxation. Download figure Open in new tab Figure 7: Radius of gyration (Rg) profiles of apo -ClpK and ClpK-compound complexes analysed over 100 ns. In the presence of A) NaCl and B) MgCl 2 . C) Mean Rg values (nm) of ClpK in apo and ligand bound states. The SASA represents the portion of the protein that is exposed to surrounding solvent molecules and is important for protein solvation and compactness analysis ( Borjian Boroujeni et al ., 2021 ). The average SASA of apo-ClpK was observed to be 514.25 nm/S 2 /N in the presence of NaCl and 504.86 nm/S 2 /N in the presence of MgCl 2 , indicating a slightly more compact conformation under MgCl 2 conditions. A lower SASA indicates reduced solvent exposure, this is associated with tighter protein packing and correlates with the slight increase in Rg observed in Figure 6 in the presence of MgCl 2 . In the presence of ligands, an increase in average SASA was observed under both ionic conditions. This increase could be attributed to ligand induced conformational changes in the surface-exposed regions of ligand binding sites which may cause protein unfolding or expansion of the surface area ( Figure 8 ). Additionally, increased SASA values indicating structural relaxation and therefore a decrease in protein stability ( Borjian Boroujeni et al ., 2021 ). Download figure Open in new tab Figure 8: SASA profiles of apo -ClpK and ClpK-compound complexes analysed over 100 ns. In the presence of A) NaCl and B) MgCl 2 . The number of hydrogen bonds between proteins and ligands can be investigated to evaluate interaction stability ( Molaakbari et al ., 2024 ). To evaluate the dynamic nature of these interactions, the number and persistence was investigated in the presence of NaCl and MgCl 2 ( Figure 9 ). A high diversity and fluctuation of hydrogen bonds is observed in the presence of NaCl ( Figure 9A ), however in the presence of MgCl 2 the hydrogen bonds are more stable and persistent ( Figure 9B ). The MD simulations indicate that the ionic environment and ligand binding influence the global structural dynamics of ClpK. Download figure Open in new tab Figure 9: Hydrogen bond count between ClpK and compounds over the course of molecular dynamic simulations. The number of hydrogen bonds formed was investigated in the presence of A) NaCl and B) MgCl 2 . Table 6 summarises the binding free energies values for the ClpK-compound complexes in the presence of NaCl and MgCl 2 , as calculated using MM-GBSA. Negative values indicate favourable binding. In the presence of NaCl, ADEP3 (-41.39 kcal/mol) had the lowest binding energy, followed by Sclerotiamide (-35.65 kcal/mol) and ADEP1 (-35.43 kcal/mol). Similarly, in the presence of MgCl 2 , ADEP3 (-42.59 kcal/mol) remained the most favourable binder, followed by ADEP2 (-34.03 kcal/mol) and Sclerotiamide B (27.70 kcal/mol). Interestingly, ADEP3 had the lowest binding affinity in the presence of both NaCl and MgCl 2 suggesting that ADEP3 may be the most stable and effective binder to ClpK among the tested compounds. The binding energies of some compounds varied significantly between some compounds. View this table: View inline View popup Download powerpoint Table 6: Molecular Mechanics Generalized Born Surface Area (MM-GBSA) analysis of the binding free energy of ClpK and compounds. 1.3. Discussion K. pneumoniae is a multidrug resistant, WHO-designated priority pathogen that urgently requires the development of new therapeutic strategies. The ClpK ATPase, implicated in protein homeostasis and stress tolerance, represents a potential target for therapeutic development ( Shrivastava et al ., 2018 , Abbas et al ., 2024 ). In this study, in silico approaches were used to investigate the binding efficiency and dynamic stability of selected natural and synthetic compounds with ClpK under varying ionic conditions. Binding site prediction in the ClpK homology model revealed 14 potential binding pockets, five of which were classified as druggable based on the pocket size and SimpleScore metrics ( Figure 2 ). Computational binding sites prediction provides a valuable first step in drug discovery however, they may be limited by data quality and standardisation challenges ( Stratiichuk et al ., 2025 ). To explore the functional significance of these predicted sites, molecular docking and molecular-dynamics simulations were subsequently performed to evaluate ligand binding, interaction stability, and potential inhibitory effects. A preliminary screening of natural and synthetic compounds ( Tables 2 - 4 ) enabled the exclusion of molecules with unfavourable ADMET characteristics, refining the selection for downstream docking and dynamics studies. Docking analysis identified several high affinity compounds, mainly the sclerotiamide derivates and ADEP analogues ( Table 4 ) and this is consistent with findings that reported sclerotiamide activates ClpP, while ADEP can act as both a ClpP activator and inhibitor ( Vass and Chien, 2016 , Lavey et al ., 2016 ). To further characterise binding, ligand interaction profiling was conducted for the top ten compounds. Compounds were observed to form hydrogen bonds, π-π stacking, and hydrophobic interactions with residues within key functional domains of ClpK including, the N-terminal domain, NBD1, D1-small domain, and NBD2 ( Figure 3 ). These interactions reinforced binding stability and specificity with hydrogen bonds orientating the ligands, π-π stacking enhancing affinity and hydrophobic contacts enhancing stability ( Madushanka et al ., 2023 , Brylinski, 2018 , Ferenczy and Kellermayer, 2022 ). Additionally, the involvement of multiple domains is advantageous for drug development potentially offering avenues for the development of compounds that disrupt ClpK’s interdomain interaction and ATPase function ( Ferrari et al ., 2003 ). The structural dynamics of these multi-domain interactions were investigated using 100 ns MD simulations with NaCl and MgCl 2 to explore how these ionic conditions effect structural stability and flexibility. Since ionic environments can alter protein electrostatics, conformational flexibility, and ligand stability, this comparison can provide an insight into the physiochemical factors that can influence inhibitor binding ( Schönichen et al ., 2013 ). The potential energy profiles of apo -ClpK and ligand-bound complexes remained stable throughout the simulations ( Figure 4 ). Suggesting that complexes were energetically and thermodynamically stable, allowing for the reliable interpretation of structural and dynamic parameters ( Ajao et al ., 2012 ). RMSD trajectories ( Figure 5 ) revealed distinct stability profiles under the two ionic conditions. In the presence of NaCl, the average RMSD values increased upon ligand binding, with the sclerotiamide N complex exhibiting the highest deviation. In contrast, systems exhibited slightly higher RMSD fluctuation in MgCl 2 suggesting enhanced overall flexibility. This indicates that the stronger electrostatic influence of Mg 2+ ions may perturb intramolecular interactions and promote local rearrangements in the protein backbone ( Schauss et al ., 2021 ). This observation is consistent with findings reported by Shao et al . (2022) , where simulations of protein 1BBL in the presence of MgCl 2 also showed increased RMSD values, indicating enhanced protein dynamics at moderate salt concentrations. In the presence of MgCl 2 , Sclerotiamide B and ADEP3 complexes maintained stable ligand binding, while ADEP2 increased average RMSD values suggesting destabilisation. Overall, RMSD values showed that most complexes reached equilibrium within the 100 ns timeframe. RMSF analysis ( Figure 6 ) was consistent with the RMSD findings and provided an insight into local dynamics. A moderate increase in residue level fluctuations were observed in the presence of NaCl, with the binding of Sclerotiamide N exhibiting the highest fluctuation. In contrast, elevated peaks were observed in the presence of MgCl 2 particularly in the C-terminal region. Increased fluctuations observed for the ADEP2 and ADEP5 complexes indicated that specific ligand interactions may induce local destabilisation in the presence of MgCl 2 . Complementary analysis of Rg ( Figure 7 ) further investigated the influence of ions on the overall structural organisation. ClpK-ligand complexes maintained relatively consistent Rg values in the presence of NaCl, indicating preserved structural compactness and stable folding ( Motiwala et al ., 2025 ). In contrast, higher Rg values with more pronounced fluctuations were observed in the presence of MgCl 2 indicating increased structural flexibility. This corresponds with the observed RMSD trends which indicate that the Mg 2+ ions promote a more relaxed conformational state. However, all complexes reached equilibrium by the end of the 100 ns simulation time, indicating overall complex stability under both ionic conditions suggesting that ionic composition modulates ClpK-ligand interactions. The ion-dependent difference in protein-ligand interaction stability were further investigated through SASA analysis ( Figure 8 ). The average SASA of apo-ClpK decreased in the presence of MgCl 2 suggesting that a more compact protein conformation is promoted under these conditions. This is also observed for the ClpK-ligand complexes where lower SASA values in the presence of MgCl 2 suggest reduced solvent exposure and enhances structural compactness. In contrast, in the presence of NaCl higher and more fluctuating SASA values are observed therefore indicating structural relaxation ( Borjian Boroujeni et al ., 2021 ). This variability can further be supported through hydrogen bonding analyses ( Figure 9 ). It was observed that NaCl promoted more diverse and fluctuating hydrogen bond patterns suggesting dynamic and transient interactions. In contrast, stable and persistent hydrogen bonds were observed in the presence of MgCl 2 suggesting stronger electrostatic stabilisation and reduced conformational mobility. These structural observations were consistent with MM-GBSA binding free energy results ( Table 5 ) where the negative binding free energy values of all complexes indicated that the compounds bind to ClpK under both ionic conditions, supporting their potential biological relevance. Additionally, these findings highlight the importance of carefully considering buffer composition in molecular simulations and drug screening workflows due to the influence ionic interactions can have on predicted binding behaviours. In conclusion, this study provides a foundation for future in vitro studies that focus on validating the predicted interactions. To validate the in silico findings, it is important to assess ClpK ATPase activity in the presence of these ligands. These experiments should be performed under varying physiological conditions, including different pH levels and salt concentrations to reflect the dynamic intracellular environment. Additionally, the impact of these compounds on ClpK thermal stability would offer insights into their potential to function as stabilisers or destabilisers of ClpK. Collectively, these studies would help confirm the biological relevance of the predicted interactions and further support the development of ClpK as a promising therapeutic target against K. pneumoniae . 1.4. Materials and Methods 1.4.1. ClpK Modelling and Analysis ClpK was modelled using the AlphaFold server, which predicts three-dimensional (3D) structures using the primary protein sequence ( Jumper et al ., 2021 , Schwede et al ., 2003 , Ko et al ., 2012 ). The modelled structure was evaluated using the MolProbity, VADAR (Volume, Area, Dihedral Angle Reporter) version 1.8, Protein Structure Analysis (ProSA) web server, ERRAT module on the saves Saves v1.6 and the SWISS MODEL structure assessment tool ( Williams et al ., 2018 , Wiederstein and Sippl, 2007 , Waterhouse et al ., 2018 , Willard et al ., 2003 , Colovos and Yeates, 1993 ). ClpK binding sites were identified using the DoGSiteScorer module on the ProteinPlus server ( https://proteins.plus/ , Accessed 12 August 2024). 1.4.2. Ligand preparation The ligands dihydrothiazepine 334 and 336 were drawn using the ChemSketch software while the ADEP1 structure was derived from PDB ID: 3KT and sketched on the ChemSketch software using the SMILES obtained from the Protein Data Bank (PDB). Additional ligands namely, ADEP2 to ADEP 5, Armeniaspirols, phenyl ester compounds (AV126, AV145, AV167, AV170), synthetic peptidomimetic boronate inhibitors (D3, E2, G2, U1), and Hydantoin derivatives were drawn using image identification on the KingDraw software. All ligand structures were saved as .mol files. Sclerotiamide (CID: 10647785), Sclerotiamide P (CID: 170989817), Sclerotiamide L (CID: 170989811), Sclerotiamide N (CID: 170989813), Cyclomarin A (CID: 10772429), Lassomycin (CID: 132528125), Ecumicin ( CID: 101894301 ), Rufomycin B (CID: 76871757), Sclerotiamide B (CID: 146682810), Quercetin (CID: 5280343), Epigallocatechin gallate (EGCG) (CID: 65064), Kaempferol (CID: 5280863), Fisetin (CID: 5281614), Apigenin (CID: 5280443), Luteolin (CID: 5280445) and Genistein (CID: 5280961) were downloaded in the .sdf format from PubChem ( https://pubchem.ncbi.nlm.nih.gov/ , Accessed 29 July 2024). 1.4.3. Ligand ADMET and Toxicity Analysis The ProTox 3.0 server was used to predict the toxicity of the small ligands to ensure that they were suitable for use in humans ( Banerjee et al ., 2024 ). The SWISSADME server ( http://www.swissadme.ch/ ; Accessed 30 July 2024) was used to determine the pharmacodynamics of the small ligands through ADME (Adsorption, Distribution, Metabolism, Excretion) analysis ( Daina et al ., 2017 ). The pkCSM server was used to predict ADMET properties of the large ligands ( Pires et al ., 2015 ). 1.4.4. Molecular Docking studies The ligands selected for analysis were prepared using the LipPrep module on the Maestro Schrodinger software ( Yang et al ., 2021 ). Molecular docking was performed using the Autodock vina program integrated on the PyRx software ( Ayodele et al ., 2023 ). Briefly, the prepared protein was loaded into the PyRx software and made into a macromolecule for docking analysis. The ligands were then loaded into the PyRx software and converted into ligands for docking and saved as .pdbqt files. The grid (Center: X = - 1.1473, Y = -1.1450, Z = -3.1984, Dimensions: X = 93.9220, Y = 105.3030, Z = 107.8333) was set to cover the entirety of ClpK and docking was performed. ClpK-ligand interactions were visualised using Discovery Studio Visualiser 2023 v24.1.0.23298 and PyMol ( Schrödinger, 2015 ). 1.4.5. Molecular dynamics simulations using GROMACS Molecular dynamics (MD) simulations are computational methods used to predict how protein atoms or other organic systems move over time ( Hollingsworth and Dror, 2018 ). MD simulations were performed using GROMACS, an open-source and widely used software package for biomolecular simulation ( Abraham et al ., 2015 ). The Graphics processing unit (GPU)-accelerated version of GROMACS v2024.2 was installed on a Windows Subsystem for Linux (WSL) 2. Simulations were performed for 100 ns on ClpK alone and selected ClpK-ligand complexes in the presence of either 0.15 M NaCl and 0.05 M MgCl 2 , to assess structural stability and interaction dynamics. The simulation workflow was adapted based on established protocols available on the official GROMACS tutorial website ( http://www.mdtutorials.com/gmx/ ) and is briefly summarised below ( Lemkul, 2018 ). 1.4.5.1. ClpK MD simulation of in the absence of ligands The refined ClpK model was subjected to MD simulation using GROMACS. The initial structure file (protein.pdb) was processed using the pdb2gmx module to generate the topology, position restraint and post-processed (protein.gro) structure files. The all-atom Optimized Potentials for Liquid Simulations (OPLS) forcefield was used, and solvent model specified as SPC/E. A triclinic simulation box was generated with a minimum distance of 1.0 nm between ClpK and box edges. Solvation was performed using transferable intermolecular potential with 3 points (TIP3P) water model with the predefined SPC216 configuration. The system was then neutralised, and ions were added (either 0.15 M NaCl or 0.05 M MgCl 2 ). Energy minimisation was performed using the steepest descent algorithm for 50000 steps to relieve steric clashes and optimize the initial geometry. The system was the equilibrated in two steps: NVT (number of particles, volume, temperature) and NPT (number of particles, pressure, temperature). The 100 ps NVT ensemble was used to stabilise the temperature at 300 K. The 100 ps NPT ensemble was used to stabilise the pressure at 1 bar. A production MD was subsequently performed for 100 ns using a 2 fs time step. The Leap-frog integrator was used to solve the equations of motion and Verlet cut-off scheme was used to evaluate short-ranged non-bonded interactions. Temperature coupling was controlled using the modified Berendsen thermostat, and pressure coupling was controlled using the Parrinello-Rahman barostat. Long-range electrostatic interactions were calculated using the Particle Mesh Ewald (PME) method. 1.4.5.2. ClpK-ligand bound MD simulations To prepare the ClpK-ligand complexes for MD simulations, ClpK and ligand files were saved as separate files. ClpK structure was processed using the Charmm36-jul2022 force field and solvated using the TIP3P water model. The resulting ClpK_processed.gro file was visualised in PyMol to ensure successful model processing. Ligand preparation was performed using Open Babel and Networkx v2.3. A perl script for ligand topology generation was obtained from the GROMACS tutorial site ( http://www.mdtutorials.com/gmx/complex/02_topology.html ). The ligand.pdb file was converted to ligand.mol2 using Open Babel. The ligand.mol2 file manually edited using a text editor to ensure consistent naming of the ligand (renamed to “LIG”) across the header and atom records, and the bond order was verified. The edited ligand_fix.mol2 file was submitted to the CHARMM General Force Field server (CGennFF) ( https://app.cgenff.com/homepage ) to generate topology and parameter files (ligand.str). The generated ligand_ini.pdb file was converted to ligand.gro, which was visualised in PyMol to ensure confirm correct formatting and structure. The processed ClpK and ligand files were then combined using a text editor tool and visualised in PyMol to verify proper merging of the complex. The system topology file (topol.top) was manually updated to include ligand topology and parameters. A triclinic simulation box was defined with a 1.0 nm buffer around the complex, and system was solvated using the TIP3P water model. The solvated system was visualised using PyMol to confirm that the ClpK-ligand complex was centred within the box. The system was then neutralised and either 0.15 M NaCl or 0.05 M MgCl 2 was added. Visual inspection using PyMol confirmed the presence of ions. Energy minimisation was performed to relieve any steric clashes. Prior to equilibration, the ligand was restrained and temperature coupling groups were defined. A position restrain topology file for the ligand was appended to the end of the system topology file. The index.ndx file was examined to confirm successful definition of ClpK, ligand, and solvent groups. Equilibration parameter files (nvt.mdp, md.mdp and npt.mdp) were adapted from the GROMACS tutorial and modified to reflect the custom groups. NVT equilibration was performed for 100 ps at 300K, followed by NPT equilibration for 100 ps at 1 bar. A 100 ns production MD simulation was then performed to evaluate structural dynamics and protein-ligand complex stability. 1.4.6. Molecular dynamic simulation post-run analysis Following the MD simulations, trajectory post-processing was performed to correct for periodic boundary conditions (PBC), which cause the protein to appear broken or diffused across the unit cell. For the apo -ClpK simulation the following analyses were conducted: root mean square deviation (RMSD), root mean square fluctuation (RMSF), potential energy, and radius of gyration (Rg). For the ClpK-ligand complexes, additional analyses were conducted to investigate the impact of ligand binding, these included: RMSD, RMSF, Rg, potential energy, hydrogen bond analysis, Solvent Accessible Surface Area (SASA), and Molecular Mechanics/Generalized Born Surface Area (MM/GBSA) ( Bondi, 1964 ). 1.5. Author Contributions Conceptualization, T.K.; methodology, T.B., and T.K.; data curation T.B.; modelling, T.B., and T.K.; validation, T.B., and T.K.; molecular dynamic simulations, T.B.; formal analysis, T.B. and T.K.; investigation, T.B. and T.K.; protein expression and optimization, T.B.; biophysical characterization, T.B., and T.K. writing—original draft preparation, T.B.; writing—review and editing, T.B., and T.K.; visualization, T.B., and T.K.; supervision, T.K.; project administration, T.K.; All authors have read and agreed to the published version of the manuscript. 1.6. Funding Tehrim Ballim would like to thank Department of Science and Technology-National Research Foundation (DST-NRF), South Africa for the Doctoral Scholarship with Grant Number MND210602605517. Thandeka Khoza also thanks the National Research Foundation Grant number 121275, South African Medical Research Council-SIR grant and University of KwaZulu-Natal for research grants. 1.7. Conflicts of Interest The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the result. Footnotes 216013319{at}stu.ukzn.ac.za (T.M.). References ↵ Abbas , R. , Chakkour , M. , Zein El Dine , H. , Obaseki , E. F. , Obeid , S. T. , Jezzini , A. , Ghssein , G. & Ezzeddine , Z. 2024 . General Overview of Klebsiella pneumonia: Epidemiology and the Role of Siderophores in Its Pathogenicity . Biology , 13 , 78 . OpenUrl PubMed ↵ Abraham , M. J. , Murtola , T. , Schulz , R. , Páll , S. , Smith , J. C. , Hess , B. & Lindahl , E . 2015 . GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers . SoftwareX , 1-2, 19-25. ↵ Afriza , D. , Suriyah , W. H. & Ichwan , S. J. A . 2018 . In silico analysis of molecular interactions between the anti-apoptotic protein survivin and dentatin, nordentatin, and quercetin . Journal of Physics: Conference Series , 1073 , 032001 . OpenUrl ↵ Ajao , A. , Kannan , M. , Yakubu , S. , Vj , U. & Jb , A . 2012 . Homology modeling, simulation and molecular docking studies of catechol-2, 3-Dioxygenase from Burkholderia cepacia: Involved in degradation of Petroleum hydrocarbons . Bioinformation , 8 , 848 – 54 . OpenUrl PubMed ↵ Alazmi , M. & Motwalli , O . 2021 . In silico virtual screening, characterization, docking and molecular dynamics studies of crucial SARS-CoV-2 proteins . J Biomol Struct Dyn , 39 , 6761 – 6771 . OpenUrl PubMed ↵ Ali , A. , Mir , G. J. , Ayaz , A. , Maqbool , I. , Ahmad , S. B. , Mushtaq , S. , Khan , A. , Mir , T. M. & Rehman , M. U . 2023 . In silico analysis and molecular docking studies of natural compounds of Withania somnifera against bovine NLRP9 . Journal of Molecular Modeling , 29 , 171 . OpenUrl ↵ Ayodele , P. , Bamigbade , A. , Bamigbade , O. , Adeniyi , I. , Tachin , E. , Seweje , A. & Farohunbi , S . 2023 . Illustrated Procedure to Perform Molecular Docking Using PyRx and Biovia Discovery Studio Visualizer: A Case Study of 10kt With Atropine . Progress in Drug Discovery & Biomedical Science , 6 , 1 – 32 . OpenUrl ↵ Bagley , S. T . 1985 . Habitat Association of Klebsiella Species . Infection Control , 6 , 52 – 58 . OpenUrl CrossRef PubMed Web of Science ↵ Banerjee , P. , Kemmler , E. , Dunkel , M. & Preissner , R . 2024 . ProTox 3.0: a webserver for the prediction of toxicity of chemicals . Nucleic Acids Research , 52 , W513 – W520 . OpenUrl CrossRef PubMed ↵ Berg , J. M. , Tymoczko , J. L. & Stryer , L . 2007 . Biochemistry (loose-leaf) , Macmillan . Bhandari , V. , Wong , K. S. , Zhou , J. L. , Mabanglo , M. F. , Batey , R. A. & Houry , W. A . 2018 . The Role of ClpP Protease in Bacterial Pathogenesis and Human Diseases . ACS Chem Biol , 13 , 1413 – 1425 . OpenUrl CrossRef PubMed ↵ Bojer , M. S. , Hammerum , A. M. , Jørgensen , S. L. , Hansen , F. , Olsen , S. S. , Krogfelt , K. A. & Struve , C . 2012 . Concurrent emergence of multidrug resistance and heat resistance by CTX-M-15-encoding conjugative plasmids in lebsiella pneumoniae . APMIS , 120 , 699 – 705 . OpenUrl CrossRef PubMed Web of Science ↵ Bojer , M. S. , Struve , C. , Ingmer , H. , Hansen , D. S. & Krogfelt , K. A . 2010 . Heat resistance mediated by a new plasmid encoded Clp ATPase, ClpK, as a possible novel mechanism for nosocomial persistence of Klebsiella pneumoniae . PLoS One , 5 , e15467 . OpenUrl CrossRef PubMed ↵ Bondi , A . 1964 . van der Waals Volumes and Radii . The Journal of Physical Chemistry , 68 , 441 – 451 . OpenUrl CrossRef Web of Science ↵ Borjian Boroujeni , M. , Shahbazi Dastjerdeh , M. , Shokrgozar , M. , Rahimi , H. & Omidinia , E. 2021 . Computational driven molecular dynamics simulation of keratinocyte growth factor behavior at different pH conditions . Informatics in Medicine Unlocked , 23 , 100514 . OpenUrl ↵ Bouchnak , I. & Van Wijk , K. J. 2021 . Structure, function, and substrates of Clp AAA+ protease systems in cyanobacteria, plastids, and apicoplasts: A comparative analysis . Journal of Biological Chemistry , 296 . ↵ Brylinski , M . 2018 . Aromatic interactions at the ligand-protein interface: Implications for the development of docking scoring functions . Chem Biol Drug Des , 91 , 380 – 390 . OpenUrl CrossRef PubMed ↵ Carroni , M. , Franke , K. B. , Maurer , M. , Jäger , J. , Hantke , I. , Gloge , F. , Linder , D. , Gremer , S. , Turgay , K. , Bukau , B. & Mogk , A . 2017 . Regulatory coiled-coil domains promote head-to-head assemblies of AAA+ chaperones essential for tunable activity control . eLife , 6 , e30120 . OpenUrl CrossRef PubMed ↵ Chaturvedi , U. C. & Shrivastava , R . 2005 . Interaction of viral proteins with metal ions: role in maintaining the structure and functions of viruses . FEMS Immunol Med Microbiol , 43 , 105 – 14 . OpenUrl CrossRef PubMed Choules , M. P. , Wolf , N. M. , Lee , H. , Anderson , J. R. , Grzelak , E. M. , Wang , Y. , Ma , R. , Gao , W. , Mcalpine , J. B. , Jin , Y. Y. , Cheng , J. , Lee , H. , Suh , J. W. , Duc , N. M. , Paik , S. , Choe , J. H. , Jo , E. K. , Chang , C. L. , Lee , J. S. , Jaki , B. U. , Pauli , G. F. , Franzblau , S. G. & Cho , S . 2019 . Rufomycin Targets ClpC1 Proteolysis in Mycobacterium tuberculosis and M. abscessus . Antimicrob Agents Chemother , 63 . ↵ Colovos , C. & Yeates , T. O . 1993 . Verification of protein structures: patterns of nonbonded atomic interactions . Protein Sci , 2 , 1511 – 9 . OpenUrl CrossRef PubMed Web of Science ↵ Culp , E. & Wright , G. D . 2017 . Bacterial proteases, untapped antimicrobial drug targets . The Journal of Antibiotics , 70 , 366 – 377 . OpenUrl CrossRef PubMed ↵ Daina , A. , Michielin , O. & Zoete , V . 2017 . SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules . Sci Rep , 7 , 42717 . OpenUrl CrossRef PubMed ↵ Daya , T. , Jeje , O. , Maake , R. , Chinyere , A. , Khoza , T. & Achilonu , I . 2022 . Expression, Purification, and Biophysical Characterization of Klebsiella Pneumoniae Nicotinate Nucleotide Adenylyltransferase . The Protein Journal , 41 , 1 – 16 . OpenUrl CrossRef PubMed De Campos , L. J. , Seleem , M. A. , Feng , J. , Pires De Oliveira , K. M. , De Andrade Dos Santos , J. V. , Hayer , S. , Clayton , J. B. , Kathi , S. , Fisher , D. J. , Ouellette , S. P. & Conda-Sheridan , M. 2023 . Design, Biological Evaluation, and Computer-Aided Analysis of Dihydrothiazepines as Selective Antichlamydial Agents . J Med Chem , 66 , 2116 – 2142 . OpenUrl PubMed ↵ Ferenczy , G. G. & Kellermayer , M . 2022 . Contribution of hydrophobic interactions to protein mechanical stability . Comput Struct Biotechnol J , 20 , 1946 – 1956 . OpenUrl PubMed ↵ Ferrari , S. , Costi , P. M. & Wade , R. C . 2003 . Inhibitor Specificity via Protein Dynamics: Insights from the Design of Antibacterial Agents Targeted Against Thymidylate Synthase . Chemistry & Biology , 10 , 1183 – 1193 . OpenUrl CrossRef PubMed Web of Science Fetzer , C. , Korotkov , V. S. & Sieber , S. A . 2019 . Hydantoin analogs inhibit the fully assembled ClpXP protease without affecting the individual peptidase and chaperone domains . Organic & Biomolecular Chemistry , 17 , 7124 – 7127 . OpenUrl PubMed Fetzer , C. , Korotkov , V. S. , Thänert , R. , Lee , K. M. , Neuenschwander , M. , Von Kries , J. P. , Medina , E. & Sieber , S. A. 2017 . A Chemical Disruptor of the ClpX Chaperone Complex Attenuates the Virulence of Multidrug-Resistant Staphylococcus aureus . Angewandte Chemie International Edition , 56 , 15746 – 15750 . OpenUrl PubMed Gavrish , E. , Sit , C. S. , Cao , S. , Kandror , O. , Spoering , A. , Peoples , A. , Ling , L. , Fetterman , A. , Hughes , D. , Bissell , A. , Torrey , H. , Akopian , T. , Mueller , A. , Epstein , S. , Goldberg , A. , Clardy , J. & Lewis , K . 2014 . Lassomycin, a ribosomally synthesized cyclic peptide, kills mycobacterium tuberculosis by targeting the ATP-dependent protease ClpC1P1P2 . Chem Biol , 21 , 509 – 518 . OpenUrl CrossRef PubMed ↵ Gersch , M. , Famulla , K. , Dahmen , M. , Göbl , C. , Malik , I. , Richter , K. , Korotkov , V. S. , Sass , P. , Rübsamen-Schaeff , H. , Madl , T. , Brötz-Oesterhelt , H. & Sieber , S. A . 2015 . AAA+ chaperones and acyldepsipeptides activate the ClpP protease via conformational control . Nature Communications , 6 , 6320 . OpenUrl PubMed Hackl , M. W. , Lakemeyer , M. , Dahmen , M. , Glaser , M. , Pahl , A. , Lorenz-Baath , K. , Menzel , T. , Sievers , S. , Böttcher , T. , Antes , I. , Waldmann , H. & Sieber , S. A . 2015 . Phenyl Esters Are Potent Inhibitors of Caseinolytic Protease P and Reveal a Stereogenic Switch for Deoligomerization . J Am Chem Soc , 137 , 8475 – 83 . OpenUrl PubMed ↵ Han , S. , Mei , L. , Quach , T. , Porter , C. & Trevaskis , N . 2021 . Lipophilic Conjugates of Drugs: A Tool to Improve Drug Pharmacokinetic and Therapeutic Profiles . Pharm Res , 38 , 1497 – 1518 . OpenUrl PubMed ↵ Hollingsworth , S. A. & Dror , R. O . 2018 . Molecular Dynamics Simulation for All . Neuron , 99 , 1129 – 1143 . OpenUrl CrossRef PubMed Ishikawa , F. , Homma , M. , Tanabe , G. & Uchihashi , T . 2024 . Protein degradation by a component of the chaperonin-linked protease ClpP . Genes to Cells, n/a . ↵ Jernigan , R. L. , Khade , P. , Kumar , A. & Kloczkowski , A . 2022 . Using Surface Hydrophobicity Together with Empirical Potentials to Identify Protein-Protein Binding Sites: Application to the Interactions of E-cadherins . Methods Mol Biol , 2340 , 41 – 50 . OpenUrl PubMed ↵ Jumper , J. , Evans , R. , Pritzel , A. , Green , T. , Figurnov , M. , Ronneberger , O. , Tunyasuvunakool , K. , Bates , R. , Žídek , A. , Potapenko , A. , Bridgland , A. , Meyer , C. , Kohl , S. a. A. , Ballard , A. J. , Cowie , A. , Romera-Paredes , B. , Nikolov , S. , Jain , R. , Adler , J. , Back , T. , Petersen , S. , Reiman , D. , Clancy , E. , Zielinski , M. , Steinegger , M. , Pacholska , M. , Berghammer , T. , Bodenstein , S. , Silver , D. , Vinyals , O. , Senior , A. W. , Kavukcuoglu , K. , Kohli , P. & Hassabis , D. 2021 . Highly accurate protein structure prediction with AlphaFold . Nature , 596 , 583 – 589 . OpenUrl CrossRef PubMed ↵ Khan , N. , Syed , D. N. , Ahmad , N. & Mukhtar , H . 2013 . Fisetin: a dietary antioxidant for health promotion . Antioxid Redox Signal , 19 , 151 – 62 . OpenUrl CrossRef PubMed Kirstein , J. , Hoffmann , A. , Lilie , H. , Schmidt , R. , Rübsamen-Waigmann , H. , Brötz-Oesterhelt , H. , Mogk , A. & Turgay , K . 2009 . The antibiotic ADEP reprogrammes ClpP, switching it from a regulated to an uncontrolled protease . EMBO Mol Med , 1 , 37 – 49 . OpenUrl Abstract / FREE Full Text ↵ Ko , J. , Park , H. , Heo , L. & Seok , C . 2012 . GalaxyWEB server for protein structure prediction and refinement . Nucleic Acids Research , 40 , W294 – W297 . OpenUrl CrossRef PubMed Web of Science Labana , P. , Dornan , M. H. , Lafrenière , M. , Czarny , T. L. , Brown , E. D. , Pezacki , J. P. & Boddy , C. N . 2021 . Armeniaspirols inhibit the AAA+ proteases ClpXP and ClpYQ leading to cell division arrest in Gram-positive bacteria . Cell Chemical Biology , 28 , 1703 – 1715 .e11. OpenUrl PubMed ↵ Lairson , L. L. , Henrissat , B. , Davies , G. J. & Withers , S. G . 2008 . Glycosyltransferases: Structures, Functions, and Mechanisms . Annual Review of Biochemistry , 77 , 521 – 555 . OpenUrl CrossRef PubMed Web of Science ↵ Lavey , N. P. , Coker , J. A. , Ruben , E. A. & Duerfeldt , A. S . 2016 . Sclerotiamide: The First Non-Peptide-Based Natural Product Activator of Bacterial Caseinolytic Protease P . J Nat Prod , 79 , 1193 – 7 . OpenUrl CrossRef ↵ Lemkul , J. A . 2018 . From Proteins to Perturbed Hamiltonians: A Suite of Tutorials for the GROMACS-2018 Molecular Simulation Package [Article v1.0] . Living Journal of Computational Molecular Science , 1 , 5068 . OpenUrl ↵ Li , Y. , Kumar , S. , Zhang , L. , Wu , H. & Wu , H . 2023 . Characteristics of antibiotic resistance mechanisms and genes of Klebsiella pneumoniae . Open Medicine , 18 . ↵ Madushanka , A. , Moura , R. T. , Verma , N. & Kraka , E . 2023 . Quantum Mechanical Assessment of Protein–Ligand Hydrogen Bond Strength Patterns: Insights from Semiempirical Tight-Binding and Local Vibrational Mode Theory . International Journal of Molecular Sciences , 24 , 6311 . OpenUrl PubMed ↵ Martin , Y . 2005 . A Bioavailability Score . Journal of medicinal chemistry , 48 , 3164 – 70 . OpenUrl CrossRef PubMed Web of Science ↵ Mfeka , M. , Onisuru , O. , Pandian , R. P. , Sayed , Y. , Khoza , T. & Achilonu , I. 2025 . Crystal enigma: Understanding diverse protein conformational dynamics, ligand selectivity and interaction in multi-space group crystals using computational modelling . Results in Chemistry , 16 , 102288 . OpenUrl ↵ Molaakbari , E. , Aallae , M. R. , Golestanifar , F. , Garakani-Nejad , Z. , Khosravi , A. , Rezapour , M. , Eshaghi Malekshah , R. , Ghomi , M. & Ren , G . 2024 . Insilico assessment of hesperidin on SARS-CoV-2 main protease and RNA polymerase: Molecular docking and dynamics simulation approach . Biochemistry and Biophysics Reports , 39 , 101804 . OpenUrl Moreno-Cinos , C. , Goossens , K. , Salado , I. G. , Van Der Veken , P. , De Winter , H. & Augustyns , K. 2019 . ClpP Protease, a Promising Antimicrobial Target . Int J Mol Sci , 20 . ↵ Motiwala , T. , Akumadu , B. O. , Zuma , S. , Mfeka , M. S. , Chen , W. , Achilonu , I. , Syed , K. & Khoza , T . 2021 . Caseinolytic Proteins (Clp) in the Genus Klebsiella: Special Focus on ClpK . Molecules , 27 . ↵ Motiwala , T. , Mthethwa , Q. , Achilonu , I. & Khoza , T . 2022 . ESKAPE Pathogens: Looking at Clp ATPases as Potential Drug Targets . Antibiotics , 11 , 1218 . OpenUrl PubMed ↵ Motiwala , T. , Nyide , B. & Khoza , T . 2025 . Molecular dynamic simulations to assess the structural variability of ClpV from Enterobacter cloacae. Frontiers in Bioinformatics , Volume 5 – 2025 . ↵ Mulani , M. S. , Kamble , E. E. , Kumkar , S. N. , Tawre , M. S. & Pardesi , K. R . 2019 . Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review . Frontiers in Microbiology , 10 . ↵ Pires , D. E. V. , Blundell , T. L. & Ascher , D. B . 2015 . pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures . Journal of Medicinal Chemistry , 58 , 4066 – 4072 . OpenUrl CrossRef PubMed ↵ Plotniece , A. , Sobolev , A. , Supuran , C. T. , Carta , F. , Björkling , F. , Franzyk , H. , Yli-Kauhaluoma , J. , Augustyns , K. , Cos , P. , De Vooght , L. , Govaerts , M. , Aizawa , J. , Tammela , P. & Žalubovskis , R. 2023 . Selected strategies to fight pathogenic bacteria . J Enzyme Inhib Med Chem , 38 , 2155816 . OpenUrl PubMed ↵ Podschun , R. & Ullmann , U . 1998 . Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors . Clin Microbiol Rev , 11 , 589 – 603 . OpenUrl Abstract / FREE Full Text ↵ Prestinaci , F. , Pezzotti , P. & Pantosti , A . 2015 . Antimicrobial resistance: a global multifaceted phenomenon . Pathog Glob Health , 109 , 309 – 18 . OpenUrl CrossRef PubMed ↵ Rei Liao , J.-Y. & Van Wijk , K. J. 2019 . Discovery of AAA+ Protease Substrates through Trapping Approaches . Trends in Biochemical Sciences , 44 , 528 – 545 . OpenUrl CrossRef PubMed ↵ Schauss , J. , Kundu , A. , Fingerhut , B. P. & Elsaesser , T . 2021 . Magnesium Contact Ions Stabilize the Tertiary Structure of Transfer RNA: Electrostatics Mapped by Two-Dimensional Infrared Spectra and Theoretical Simulations . J Phys Chem B , 125 , 740 – 747 . OpenUrl CrossRef Schmitt , E. K. , Riwanto , M. , Sambandamurthy , V. , Roggo , S. , Miault , C. , Zwingelstein , C. , Krastel , P. , Noble , C. , Beer , D. , Rao , S. P. S. , Au , M. , Niyomrattanakit , P. , Lim , V. , Zheng , J. , Jeffery , D. , Pethe , K. & Camacho , L. R . 2011 . The Natural Product Cyclomarin Kills Mycobacterium Tuberculosis by Targeting the ClpC1 Subunit of the Caseinolytic Protease . Angewandte Chemie International Edition , 50 , 5889 – 5891 . OpenUrl PubMed ↵ Schönichen , A. , Webb , B. A. , Jacobson , M. P. & Barber , D. L . 2013 . Considering protonation as a posttranslational modification regulating protein structure and function . Annu Rev Biophys , 42 , 289 – 314 . OpenUrl CrossRef PubMed ↵ Schrödinger , L. L. C. 2015 . The PyMOL Molecular Graphics System, Version 2.5 . ↵ Schwede , T. , Kopp , J. , Guex , N. & Peitsch , M. C . 2003 . SWISS-MODEL: An automated protein homology-modeling server . Nucleic Acids Res , 31 , 3381 – 5 . OpenUrl CrossRef PubMed Web of Science ↵ Seraphim , T. V. & Houry , W. A . 2020 . AAA+ proteins . Current Biology , 30 , R251 – R257 . OpenUrl CrossRef PubMed ↵ Shamsara , J. 2018 . Correlation between Virtual Screening Performance and Binding Site Descriptors of Protein Targets . Int J Med Chem , 2018 , 3829307 . OpenUrl PubMed ↵ Shao , D. , Zhang , Q. , Xu , P. & Jiang , Z . 2022 . Effects of the Temperature and Salt Concentration on the Structural Characteristics of the Protein (PDB Code 1BBL) . Polymers , 14 , 2134 . OpenUrl PubMed ↵ Shrivastava , S. R. , Shrivastava , P. S. & Ramasamy , J . 2018 . World health organization releases global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics . Journal of Medical Society , 32 , 76 – 77 . OpenUrl CrossRef ↵ Silakari , O. & Singh , P. K . 2021 . Chapter 14 - ADMET tools: Prediction and assessment of chemical ADMET properties of NCEs . In: Silakari , O. & Singh , P. K. (eds.) Concepts and Experimental Protocols of Modelling and Informatics in Drug Design . Academic Press . ↵ Stratiichuk , R. , Melnychenko , M. , Koleiev , I. , Voitsitskyi , T. , Husak , V. , Shevchuk , N. , Ostrovsky , Z. , Bdzhola , V. , Yesylevskyy , S. , Starosyla , S. & Nafiiev , A . 2025 . Leveraging large language models for literature-driven prioritization of protein binding pockets . Bioinformatics , 41 . ↵ Varma , M. V. S. , Perumal , O. P. & Panchagnula , R . 2006 . Functional role of P-glycoprotein in limiting peroral drug absorption: optimizing drug delivery . Current Opinion in Chemical Biology , 10 , 367 – 373 . OpenUrl CrossRef PubMed ↵ Vass , R. H. & Chien , P . 2016 . Two ways to skin a cat: acyldepsipeptides antibiotics can kill bacteria through activation or inhibition of ClpP activity . Mol Microbiol , 101 , 183 – 5 . OpenUrl PubMed ↵ Volkamer , A. , Griewel , A. , Grombacher , T. & Rarey , M . 2010 . Analyzing the Topology of Active Sites: On the Prediction of Pockets and Subpockets . Journal of Chemical Information and Modeling , 50 , 2041 – 2052 . OpenUrl CrossRef PubMed ↵ Waterhouse , A. , Bertoni , M. , Bienert , S. , Studer , G. , Tauriello , G. , Gumienny , R. , Heer , F. T. , De beer, T. A p., Rempfer, C., Bordoli, L., Lepore, R. & Schwede, T. 2018 . SWISS-MODEL: homology modelling of protein structures and complexes . Nucleic Acids Research , 46 , W296 – W303 . OpenUrl CrossRef PubMed ↵ Wiederstein , M. & Sippl , M. J . 2007 . ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins . Nucleic Acids Research , 35 , W407 – W410 . OpenUrl CrossRef PubMed Web of Science ↵ Willard , L. , Ranjan , A. , Zhang , H. , Monzavi , H. , Boyko , R. F. , Sykes , B. D. & Wishart , D. S . 2003 . VADAR: a web server for quantitative evaluation of protein structure quality . Nucleic Acids Res , 31 , 3316 – 9 . OpenUrl CrossRef PubMed Web of Science ↵ Williams , C. J. , Headd , J. J. , Moriarty , N. W. , Prisant , M. G. , Videau , L. L. , Deis , L. N. , Verma , V. , Keedy , D. A. , Hintze , B. J. , Chen , V. B. , Jain , S. , Lewis , S. M. , Arendall , W. B ., 3rd, Snoeyink , J. , Adams , P. D. , Lovell , S. C. , Richardson , J. S. & Richardson , D. C. 2018 . MolProbity: More and better reference data for improved all-atom structure validation . Protein Sci , 27 , 293 – 315 . OpenUrl CrossRef PubMed ↵ Xuan , J. , Feng , W. , Wang , J. , Wang , R. , Zhang , B. , Bo , L. , Chen , Z.-S. , Yang , H. & Sun , L . 2023 . Antimicrobial peptides for combating drug-resistant bacterial infections . Drug Resistance Updates , 68 , 100954 . OpenUrl CrossRef PubMed ↵ Yang , Y. , Yao , K. , Repasky , M. P. , Leswing , K. , Abel , R. , Shoichet , B. K. & Jerome , S. V . 2021 . Efficient Exploration of Chemical Space with Docking and Deep Learning . Journal of Chemical Theory and Computation , 17 , 7106 – 7119 . OpenUrl ↵ Zanini , C. , Giribaldi , G. , Mandili , G. , Carta , F. , Crescenzio , N. , Bisaro , B. , Doria , A. , Foglia , L. , Di Montezemolo , L. C. , Timeus , F. & Turrini , F. 2007 . Inhibition of heat shock proteins (HSP) expression by quercetin and differential doxorubicin sensitization in neuroblastoma and Ewing’s sarcoma cell lines . J Neurochem , 103 , 1344 – 54 . OpenUrl CrossRef PubMed ↵ Zhao , H. & Huang , D . 2011 . Hydrogen Bonding Penalty upon Ligand Binding . PLOS ONE , 6 , e19923 . OpenUrl PubMed ↵ Zininga , T. , Ramatsui , L. , Makhado , P. B. , Makumire , S. , Achilinou , I. , Hoppe , H. , Dirr , H. & Shonhai , A . 2017 . (-)-Epigallocatechin-3-Gallate Inhibits the Chaperone Activity of Plasmodium falciparum Hsp70 Chaperones and Abrogates Their Association with Functional Partners . Molecules , 22 . View the discussion thread. Back to top Previous Next Posted November 30, 2025. Download PDF Email Thank you for your interest in spreading the word about bioRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Computational Repurposing and Phytochemical Screening of Inhibitors Against ClpK from Klebsiella pneumoniae Message Subject (Your Name) has forwarded a page to you from bioRxiv Message Body (Your Name) thought you would like to see this page from the bioRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Computational Repurposing and Phytochemical Screening of Inhibitors Against ClpK from Klebsiella pneumoniae Tehrim Ballim , Thandeka Khoza bioRxiv 2025.11.28.691150; doi: https://doi.org/10.1101/2025.11.28.691150 Share This Article: Copy Citation Tools Computational Repurposing and Phytochemical Screening of Inhibitors Against ClpK from Klebsiella pneumoniae Tehrim Ballim , Thandeka Khoza bioRxiv 2025.11.28.691150; doi: https://doi.org/10.1101/2025.11.28.691150 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Area Biochemistry Subject Areas All Articles Animal Behavior and Cognition (7619) Biochemistry (17641) Bioengineering (13865) Bioinformatics (41860) Biophysics (21408) Cancer Biology (18545) Cell Biology (25434) Clinical Trials (138) Developmental Biology (13357) Ecology (19863) Epidemiology (2067) Evolutionary Biology (24288) Genetics (15587) Genomics (22466) Immunology (17701) Microbiology (40301) Molecular Biology (17142) Neuroscience (88441) Paleontology (666) Pathology (2825) Pharmacology and Toxicology (4814) Physiology (7633) Plant Biology (15108) Scientific Communication and Education (2042) Synthetic Biology (4285) Systems Biology (9811) Zoology (2268)

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-05-28T02:00:01.590549+00:00
License: CC-BY-4.0